Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...
Globus Medical is acquiring Nevro Corp, a spinal cord stimulator company, according to a Feb. 6 news release. Globus Medical's transaction will include all shares of Nevro, which are valued at about ...
State of Alaska Department of Revenue reduced its stake in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 1.2% ...
Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).
Analyst Ryan Zimmerman from BTIG maintained a Buy rating on Globus Medical (GMED – Research ... is downplayed in favor of focusing on the Spine segment, there is potential for joint ...
The transaction furthers Globus Medical’s goal of becoming the preeminent musculoskeletal technology company in the world. Nevro’s comprehensive HFX spinal cord stimulation (SCS) platform ...
Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.
Hosted on MSN24d
Globus Medical Surges 62.1% in a Year: What's Driving the Stock?Through the past few quarters, Globus Medical has registered above-market growth in the U.S. spine business ... CAPTIVATE SOLA headless compression screw system, a fast and efficient solution ...
Stock analysts at Roth Capital dropped their FY2024 earnings per share (EPS) estimates for shares of Globus Medical in a research note issued on Monday, January 27th. Roth Capital analyst J. Wittes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results